Clinical Trial

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life

Study acronym: CaSPiN
Recruiting
View on ClinicalTrials.gov →
Summary
The study will assess the effect of cancer treatments on speech perception in noise, cognition, and hearing-related quality of life by monitoring 200 cancer patients receiving standard care for their underlying malignancy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-11; most recent amendment 2025-04-12.
Status change: Not Yet Recruiting → Recruiting 2025-04-04
Trial Details
NCT Number NCT06551857
Lead Sponsor Turku University Hospital
Conditions Cancer, Hearing Loss Ototoxic, Cognitive Decline, Quality of Life
Enrollment 250 participants
Start Date 2024-10-02
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-16